Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates

Journal of Gene Medicine

Volumn 7, Issue 2, 2005, Pages 228-236

  Fattori, Elena ^a   Cappelletti, Manuela ^a   Zampaglione, Immacolata ^a   Mennuni, Carmela ^a   Calvaruso, Francesco ^a   Arcuri, Mirko ^a   Rizzuto, Gabriella ^a   Costa, Patrizia ^a   Perretta, Gemma ^b   Ciliberto, Gennaro ^a   La Monica, Nicola ^a  

^a IRBM   (Italy)

^b Ist di Neurobiol e Med Molecolare   (Italy)

Author keywords

EPO; Gene electro transfer; Primates

Indexed keywords

ERYTHROPOIETIN; NAKED DNA; PLASMID DNA; PLASMID VECTOR;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CODON USAGE; CONTROLLED STUDY; DNA MODIFICATION; ELECTRICITY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; MALE; MONKEY; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; RODENT; TRANSGENE; WILD TYPE;

ANIMALS; BLOTTING, NORTHERN; CODON; ELECTROPORATION; ERYTHROPOIETIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOCRIT; MACACA FASCICULARIS; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; OLIGONUCLEOTIDES; PLASMIDS; PROTEIN SORTING SIGNALS; RABBITS;

ANIMALIA; MACACA FASCICULARIS; ORYCTOLAGUS CUNICULUS; PRIMATES; RODENTIA;

EID: 20044392832     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.652     Document Type: Article

References (43)

1. Blau HM, Springer ML. Molecular medicine: muscle-based gene therapy. New Engl J Med 1995; 333: 1554-1556.
2. Svensson EC, Tripathy SK, Leiden JM. Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today 1996; 2: 166-172.
3. Van Deutekon JC, Hoffman EP, Huard J. Muscle maturation: implications for gene therapy. Mol Med Today 1998; 5: 214-220.
4. Kerr DN. Chronic renal failure. In Cecil Textbook of Medicine, Beeson PD, McDermott W, Wyngaarden JB (eds). W. B. Saunders: Philadelphia, 1979; 1351-1367.
5. Eschebach JW, Abdulhadi MH, Browne JK, et al. Recombinant human erythropoietin in anaemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111: 12-15.
6. Sommer B, Rinsch C, Payen E, et al. Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts. Mol Ther 2002; 2: 155-161.
7. Seppen J, Barry SC, Harder B, Osborne WR. Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin. Blood 2001; 98: 594-596.
8. Maione D, Della Rocca C, Giannetti P, et al. An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus. Proc Natl Acad Sci U S A 2001; 98: 5986-5991.
9. Rudich SM, Zhou S, Srivastava R, Escobedo JA, Perez RV, Manning WC. Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys. J Surg Res 2000; 90: 102-108.
10. Bohl D, Bosch A, Cardona A, Salvetti A, Heard JM. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood 2000; 95: 2793-2798.
11. Klinman DM, Conover J, Leiden JM, Rosenberg AS, Sechler JM. Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid. Hum Gene Ther 1999; 10 659-665.
12. Rizzuto G, Cappelletti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci U S A 1999; 11: 6417-6422.
13. Rizzuto G, Cappelletti M, Mennuni C, et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 13: 1891-1900.
14. Descamps V, Blumenfeld N, Beuzard Y, Perricaudet M. Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vector. Arch Dermatol 1996; 10: 1207-1211.
15. Kessler PD, Podsakoff GM, Chen X, et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A 1996; 93: 14082-14087.
16. Snyder RO, Spratt SK, Lagarde C, et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997; 8: 1891-1900.
17. Zhou S, Murphy JE, Escobedo JA, Dwarki VJ. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther 1998; 5: 665-670.
18. Osborne WR, Ramesh N, Lau S, Clowes MM, Dale DC, Clowes AW. Gene therapy for long-term expression of erythropoietin in rats. Proc Natl Acad Sci U S A 1995; 92: 8055-8058.
19. Kappes JC, Wu X. Safety considerations in vector development. Somat Cell Mol Genet 2001; 26: 147-158.
20. Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002; 21: 895-913.
21. Mah C, Byrne BJ, Flotte TR. Virus-based gene delivery systems. Clin Pharmacokinet 2002; 41: 901-911.
22. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440-447.
23. Tripathy SK, Svensson EC, Black HB, et al. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc Natl Acad Sci U S A 1996; 93: 10876-108780.
24. Jiao S, Williams P, Berg RP, et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992; 3: 21-33.
25. Vitadello M, Schiaffino WV, Picard A, Scarpa M, Schiaffino S. Gene transfer in regenerating muscle. Hum Gene Ther 1994; 5: 11-18.
26. Maruyama H, Sugawa M, Moriguchi Y, et al. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum Gene Ther 2000; 11: 429-437.
27. Maruyama H, Ataka K, Gejyo F, et al. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther 2001; 8: 461-468.
28. Lamartina S, Roscilli G, Rinaudo CD, et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther 2002; 2: 199-210.
29. Kim CH, Oh Y, Lee TH. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene 1997; 199: 293-301.
30. Zucchelli S, Capone S, Fattori E, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000; 74: 11598-11607.
31. Mennuni C, Calvaruso F, Zampaglione I, et al. Hyaluronidase increases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002; 13: 355-365.
32. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994; 180: 1243-1250.
33. Golden A, Austen DA, van Schravendijk MR, Sullivan BJ, Kawasaki ES, Osburne MS. Effect of promoters and signal sequences on the production of secreted HIV-1 gp120 protein in the baculovirus system. Protein expression and purification. Protein Expr Purif 1998; 14 8-12.
34. Kohne C, Johnson A, Tom S, et al. Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator. J Cell Biochem 1999; 75: 446-461.
35. Howard LZ, Kelley C, Delogu G, Collins F, Morris S. Immunogenicity of DNA vaccines expressing tuberculosis protein fused to tissue plasminogen activator signal sequences. Infect Immun 1996; 67: 4780-4786.
36. Manno CS, Chew AJ, Hutchison S, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963-2972.
37. Herzog RW, Yang EY, Couto LB, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 1: 56-63.
38. Jiao S, Williams P, Berg RP, et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992; 3: 21-33.
39. Fewell JG, MacLaughlin F, Mehta V, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3: 574-583.
40. Draghia-Akli R, Ellis KM, Hill LA, Malone PB, Fiorotto ML. High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 2003; 17: 526-528.
41. Tollefsen S, Vordermeier M, Olsen I, et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol 2003; 57: 229-238.
42. Mir LM, Bureau MF, Gehl J, et al. Proc Natl Acad Sci U S A 1999; 96: 4262-4267.
43. Lamartina S, Silvi L, Roscilli G, et al. Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol Ther 2003; 7: 271-280.